VEGF165 delivered by Fibrin Sealant to reduce tissue necrosis

Details for Australian Patent Application No. 2009248875 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Helgerson, Sam L.; Redl, Heinz; Mittermayr, Rainer

Agent Cullens

Pub. Number AU-A-2009248875

PCT Pub. Number WO2009/143429

Priority 61/128,694 22.05.08 US

Filing date 22 May 2009

Wipo publication date 26 November 2009

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2009/143429 Priority application(s): WO2009/143429

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009248882-Reduced profile intraocular lens

2009248868-An ink containment system and ink level sensing system for an inkjet cartridge